Resources
Learn how the A-TCP helps with event contracts, waivers and insurance.
This study seeks to establish the natural history of pulmonary function decline in the A-T population.
The Platform is a patient-driven effort through which data about people with A-T are shared with researchers.
This trial was performed to see if amantadine sulphate improves ataxia or other movement disorders associated with A-T.
The A-TCP has established a program for the collection, submission and maintenance of cell lines from patients with A-T.
At the dose tested, Baclofen did not have a significant effect on tremor, eye movement or balance deficits.
Participants with A-T demonstrated lower brain activity or metabolism in the cerebellum as compared to control participants.
This trial in the Netherlands looked at the effects of nicotinamide ribose as a potential treatment for people with A-T.
If invited to complete a full proposal, applicants must submit the form as a PDF to grants@atcp.org.
Tools to measure the neurological problems in mice with ataxia-telangiectasia (A-T)